The earnings call reflects significant positive developments, such as strong revenue growth, positive trial results, and increased product utilization. However, challenges remain with an increased net loss, limited cash reserves, and constraints due to a small commercial team. While the highlights are impressive, the lowlights present notable hurdles that need addressing.

Company Guidance

During the Perimeter Medical Second Quarter 2025 Conference Call, key financial and operational metrics were highlighted. The company recorded $506,000 in revenue for the quarter ending June 30, 2025, marking a 105% increase from Q2 2024. The gross margin remained consistent at 70%. Operating expenses decreased by 22% to $4.3 million compared to the same period in 2024. Despite these improvements, Perimeter reported a net loss of $3.9 million. The company had cash and cash equivalents of approximately $1.4 million, excluding $1.6 million from a recent offering and a $745,000 grant receivable. The CEO, Adrian Mendes, emphasized ongoing efforts to commercialize the FDA-cleared S-Series OCT system, with a 25% revenue increase in the first half of 2025 compared to all of 2024. Utilization rates showed significant growth of 93% year-over-year and 35% sequentially. The company is awaiting FDA approval for its next-generation B-Series device, expected by late Q4 2025 or Q1 2026, and is preparing for an aggressive rollout. Cost-saving measures are projected to reduce operating expenses by approximately 30% starting in Q3.

Significant Revenue Growth

The company recorded revenue of $506,000 for Q2 2025, representing a 105% increase over Q2 2024. Additionally, revenue for the first six months of 2025 was 25% higher than the total for all of 2024.

Improved Operating Expenses

Operating expenses for Q2 2025 were $4.3 million, a 22% improvement from $5.5 million in the same period in 2024.

Positive Clinical Trial Results

The pivotal trial of Perimeter B-Series met its primary endpoint, demonstrating a statistically significant reduction in patients with residual cancer during surgery. The trial results were positively received at the ASBRS conference.

Increased Product Utilization

Utilization rates increased 93% year-over-year and 35% sequentially quarter-over-quarter. Surgeons have imaged over 3,000 patients using the company's technology.

Perimeter Medical Imaging AI (TSE:PINK) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

TSE:PINK Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 18, 2025	2025 (Q3)	-0.04 / -	-0.097	―	―	―
Aug 26, 2025	2025 (Q2)	-0.07 / -0.06	-0.069	20.00% (+0.01)	―	―
May 13, 2025	2025 (Q1)	- / -0.07	-0.041	-66.67% (-0.03)	―	―
Mar 26, 2025	2024 (Q4)	-0.07 / -0.06	-0.11	50.00% (+0.06)	―	―
Nov 14, 2024	2024 (Q3)	- / -0.10	-0.014	-600.00% (-0.08)	―	―
Aug 14, 2024	2024 (Q2)	-0.08 / -0.07	-0.11	37.50% (+0.04)	―	―
May 14, 2024	2024 (Q1)	-0.08 / -0.04	-0.069	40.00% (+0.03)	―	―
Mar 28, 2024	2023 (Q4)	-0.06 / -0.11	-0.062	-77.78% (-0.05)	―	―
Nov 14, 2023	2023 (Q3)	-0.07 / -0.01	-0.011	-25.00% (>-0.01)	―	―
Aug 29, 2023	2023 (Q2)	-0.10 / -0.11	-0.011	-900.00% (-0.10)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

TSE:PINK Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 26, 2025	C$0.22	C$0.20	-9.09%
May 13, 2025	C$0.39	C$0.46	+17.95%
Mar 26, 2025	C$0.58	C$0.57	-1.72%
Nov 14, 2024	C$0.46	C$0.50	+8.70%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Perimeter Medical Imaging Ai Inc (TSE:PINK) report earnings?

Perimeter Medical Imaging Ai Inc (TSE:PINK) is schdueled to report earning on Nov 18, 2025, Before Open (Confirmed).

What is Perimeter Medical Imaging Ai Inc (TSE:PINK) earnings time?

Perimeter Medical Imaging Ai Inc (TSE:PINK) earnings time is at Nov 18, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is TSE:PINK EPS forecast?

TSE:PINK EPS forecast for the fiscal quarter 2025 (Q3) is -0.04.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing